GLP-1 inhibitors are suitable for long-term weight management when guided by a healthcare professional
For individuals with needle aversion, these delivery formats may be worth discussing with a clinician - though sublingual bioavailability may differ from injectable formats
Proven weight loss that lastsbacked by science and personalization
It is clinical education for providers, not medical advice, and nothing here should be read as a treatment recommendation, protocol, or substitute for current FDA labeling
While various AD phenotypes have been proposed, type 2 inflammation is a major and common pathophysiological factor, irrespective of patient characteristics like age or ethnicity
Hiroshi Hosoda (National Cerebral and Cardiovascular Center)